Griffiths Richard Ian bought SLN
July 30, 2025 · Form 4 insider transaction
Griffiths Richard Ian bought 8,923 shares of Silence Therapeutics plc, a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,923
Price
N/A
Total value
N/A
InsiderGriffiths Richard Ian
Role—
SecurityAmerican Depositary Shares
Transaction codeP: Open-market purchase
Transaction dateJuly 30, 2025
Filing dateJuly 31, 2025
Shares owned after11,807,485
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.; The securities are held by Cream Capital Limited ("Cream"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.